313 related articles for article (PubMed ID: 28257816)
1. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
3. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
Hevia EC; Wooten L; Carr AL
Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
[TBL] [Abstract][Full Text] [Related]
7. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
8. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
Wang YL; Scipione MR; Dubrovskaya Y; Papadopoulos J
Antimicrob Agents Chemother; 2014; 58(1):176-82. PubMed ID: 24145530
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
Hand E; Davis H; Kim T; Duhon B
J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
Junco SJ; Bowman MC; Turner RB
Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
12. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?
Cho SY; Kang CI; Kim J; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2014; 58(1):581-3. PubMed ID: 24126583
[TBL] [Abstract][Full Text] [Related]
13. Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
Usarek P; Dobrzaniecka K; Szymanek-Majchrzak K; Sawicka-Grzelak A; Mlynarczyk A; Durlik M; Ciszek M; Paczek L; Chmura A; Kwiatkowski A; Mlynarczyk G
Transplant Proc; 2016 Jun; 48(5):1411-3. PubMed ID: 27496417
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron.
Hu LF; Chang X; Ye Y; Wang ZX; Shao YB; Shi W; Li X; Li JB
Int J Antimicrob Agents; 2011 Mar; 37(3):230-4. PubMed ID: 21296557
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study.
Wang CH; Lin JC; Chang FY; Yu CM; Lin WS; Yeh KM
J Microbiol Immunol Infect; 2017 Oct; 50(5):646-652. PubMed ID: 28688829
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of integrons, sul1-2 and dfr genes in trimethoprim-sulfametoxazole-resistant Stenotrophomonas maltophilia strains isolated from clinical samples].
Ozkaya E; Aydin F; Bayramoglu G; Buruk CK; Sandalli C
Mikrobiyol Bul; 2014 Apr; 48(2):201-12. PubMed ID: 24819258
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
Nys C; Cherabuddi K; Venugopalan V; Klinker KP
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427300
[No Abstract] [Full Text] [Related]
20. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
